Related Experiment Video
Updated: Jan 25, 2026

Computerized Adaptive Testing System of Functional Assessment of Stroke
Published on: January 7, 2019
Assessing testing rates for viral hepatitis B and C by general practitioners in Flanders, Belgium: a registry-based
Rob Bielen1,2, Özgür M Koc1,2,3, Dana Busschots1,2
1Faculty of Medicine and Life Sciences, Universiteit Hasselt, Hasselt, Belgium.
Insights
Hepatitis B (HBV) and C (HCV) testing by general practitioners in Flanders, Belgium, is low, even for patients with liver enzyme elevation. Increased testing is crucial for diagnosis and care.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections significantly contribute to global mortality.
- Despite available effective treatments for HBV and HCV, diagnosis rates remain low, particularly in Belgium (<50%).
- General practitioners (GPs) are pivotal in the prevention, diagnosis, and management of viral hepatitis.
Purpose of the Study:
- To evaluate the real-world testing and diagnosis rates for HBV and HCV by GPs in Flanders, Belgium.
- To assess HBV and HCV screening prevalence within primary care settings.
Main Methods:
- A retrospective analysis of electronic medical records from 48 primary care practices in Flanders, Belgium.
- Data from a central registry encompassing 440,140 patients over 20 years, representing 2.2% of the Flemish population annually.
- Analysis of testing rates for hepatitis B surface antigen (HBsAg) and hepatitis C antibody (HCV Ab), including patients with chronically elevated liver enzymes.
Main Results:
- Overall screening rates were low: 1.8% for HBsAg and 1.6% for HCV Ab among 440,140 patients.
- In patients with chronic liver enzyme elevation, testing rates were higher but still suboptimal: 7.9% for HBsAg and 9.9% for HCV Ab.
- No significant improvement in testing rates was observed over the 20-year study period.
Conclusions:
- Real-world testing uptake for viral hepatitis B and C in Flemish general practices is suboptimal.
- Testing rates remain low even in patient groups with indicators of liver disease, such as chronically elevated liver enzymes.
- Urgent implementation of strategies to enhance HBV and HCV testing uptake by GPs is necessary to improve diagnosis and patient care.
Objectives:
Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) have a major impact on mortality worldwide. Although effective treatments are available for both HBV and HCV infection, <50% of the patients are even diagnosed in Belgium. This study assessed the real-life testing-and diagnosis rate by general practitioners (GPs) in Flanders, Belgium.
Setting:
We assessed the testing rate for HBV and HCV in 48 primary care practices with electronic medical records linked into one central registry in Flanders, Belgium.
Participants:
The registry contains data of 440 140 patients over 20 years, which corresponds to 2.2% of the total Flemish population yearly. The primary care practices are distributed across Flanders and the patient population is representative for the distribution of age, gender and socioeconomic status at the community level.
Results:
Of 440 140 patients included in the registry, 7892 (1.8%) patients were screened for hepatitis B surface antigen (HBsAg) and 7206 (1.6%) for hepatitis C antibody (HCV Ab) of whom 369 (4.7%) and 163 (2.3%) tested positive, respectively. Of 14 059 patients with chronic liver enzyme elevation, 1112 (7.9%) and 1395 (9.9%) were tested for HBsAg and HCV Ab, respectively. There was no improvement in testing rates over time.
Conclusions:
This study demonstrates that real-life testing uptake for viral hepatitis B and C is suboptimal in the general practices in Flanders, even in patients with chronically elevated liver enzymes. As GPs play a crucial role in prevention, diagnosis and linkage to care, efforts and strategies to increase the testing uptake for HBV and HCV are urgently needed.
Related Concept Videos
Assessment of Ventilation I: Respiratory Rate
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Viral Recombination
Viral Structure
Reaction Rate
The mathematical representation of the change in the concentration of reactants and products, over time, is the rate...
Serum Studies: Renal Function Tests

